Regulatory News: Nulibry (Fosdenopterin) Approved To Reduce The Risk Of Mortality In Patients With Molybdenum Cofactor Deficiency Type A: Fda Approval Summary
JOURNAL OF INHERITED METABOLIC DISEASE(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要